focus -WSS

focus

author：leisure time 2025-10-01 22:58:10 - browse：988

Since the pandemic, patients have become increasingly comfortable with getting their medications online. Direct-to-consumer telehealth has made it easy to schedule a virtual visit and get a script, sometimes within minutes, with prescriptions shipped to your doorstep.

Now, Big Pharma is ready to get in on the action.

In early January, Eli Lilly announced a platform that allows patients to access and fill prescriptions for its drugs online, timing the news to the availability of its obesity medication Zepbound. Using LillyDirect, patients click into a pipeline for their condition — obesity, diabetes, or migraine — and are routed to telehealth sites that can prescribe them one of Lilly’s drugs if they’re eligible. An integration with online pharmacy Truepill will deliver the meds.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： IVG is promising — but it won’t replace IVF quite yet

WSS

What will Novo Nordisk's VC do with its influx of cash?

Bispecific antibodies are next new thing in cancer immunotherapy

The stability of $0 premiums in Medicare Advantage

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Some top drug companies are starting to take action on climate

explore

focus

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

RSV injection headlines need to be accurate for good uptake

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The Karikó problem: Lessons for funding basic research

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The Karikó problem: Lessons for funding basic research

Jerome Adams on the need for new antivirals for Covid

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

The high cost of giving birth even with insurance

Medicare innovation center doesn’t save money, experts say

focus

Bispecific antibodies are next new thing in cancer immunotherapy

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

CDC picks Alphabet's Verily for wasterwater surveillance contract

6 solutions to address cancer drug shortages and others

Bispecific antibodies are next new thing in cancer immunotherapy

Can medical device makers keep up in the race to treat obesity?

hotspot

leisure time

hotspot

knowledge